Ultragenyx Announces Participation in Key Investor Conferences
![Ultragenyx Announces Participation in Key Investor Conferences](https://investorshangout.com/images/blog/ihnews-Ultragenyx%20Announces%20Participation%20in%20Key%20Investor%20Conferences.jpg)
Ultragenyx to Participate in Investor Conferences
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for serious rare and ultrarare genetic diseases, has announced its participation in three significant investor conferences.
Morgan Stanley Annual Global Healthcare Conference
Emil Kakkis, M.D., Ph.D., the CEO and President of Ultragenyx, will participate in a fireside chat and conduct one-on-one meetings at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4. This event is an opportunity for stakeholders and investors to gain insights into the company's strategic direction and ongoing projects.
Cantor Global Healthcare Conference
On September 17, Emil Kakkis will be joined by Howard Horn, Chief Financial Officer, at the Cantor Global Healthcare Conference. Together, they will engage in a fireside chat and facilitate one-on-one meetings, providing detailed information about the company's latest developments and strategies.
Bank of America Global Healthcare Conference
Eric Crombez, M.D., Chief Medical Officer, and Joshua Higa, Vice President of Investor Relations, will represent Ultragenyx at the Bank of America Global Healthcare Conference on September 18. They will outline the company's focus on addressing rare genetic diseases and participate in a fireside chat and one-on-one meetings with investors and analysts.
Webcasting Events
The live and archived webcasts of these fireside chats will be available on the official Ultragenyx website, providing broader access to the discussions and insights shared during these conferences.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is committed to advancing the development of new therapies for patients with serious rare and ultrarare genetic diseases. By focusing on conditions with significant unmet medical needs, the company aims to provide better healthcare solutions where previous options were limited or nonexistent.
Led by an expert management team with extensive experience in the fields of drug development and commercialization, Ultragenyx emphasizes efficient drug development processes. The aim is to prioritize the swift and effective delivery of innovative therapies to patients who require them. Their efforts center on providing therapeutic options that enhance the quality of life and address the root causes of genetic disorders.
Contact Information
For inquiries related to investor relations, Joshua Higa can be reached at ir@ultragenyx.com.
Frequently Asked Questions
What is the purpose of Ultragenyx's participation in these conferences?
Ultragenyx participates in these conferences to share insights about their developments in rare genetic disease therapeutics and engage with investors.
Who is the CEO of Ultragenyx Pharmaceutical Inc.?
The CEO of Ultragenyx Pharmaceutical Inc. is Emil Kakkis, M.D., Ph.D.
When is the Morgan Stanley Annual Global Healthcare Conference?
The Morgan Stanley 22nd Annual Global Healthcare Conference is scheduled for September 4.
Which conferences will Ultragenyx attend in September?
Ultragenyx will attend the Morgan Stanley Annual Global Healthcare Conference, Cantor Global Healthcare Conference, and Bank of America Global Healthcare Conference in September.
Where can I view the webcasts of the conferences?
The webcasts of the conferences will be available on the Ultragenyx official website.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Clip Money Inc. Reports Impressive Q2 2024 Financial Results
- Perseus Mining Announces Rick Menell as Chairman
- LNG Energy Group Announces Strong Q2 2024 Results
- Serabi Gold Announces Robust Mid-Year Financial Performance
- Understanding Insider Sales: What Investors Should Know
- McDull Meme Coin: A Playful Blockchain Initiative
- BEN Partners with INTERVENT and Members Only Health for AI in Healthcare
- Hudbay Receives Key Aquifer Protection Permit for Copper World
- CUBEBIO Partners with Mountain Crest V for Public Listing
- InterCure Reports Strong Financial Performance in 2024
- Evolution Petroleum Announces Earnings Release and Call Details
- Cerro Grande Mining Corporation Reports Q3 2024 Financial Results
- ARCpoint Conference Call for Q2 2024 Financial Results
- AIP Realty Trust Reports Second Quarter 2024 Financial Results
- Mark Cuban's Journey: Building Wealth and Success
- Jura Energy Corporation Releases Interim Financial Statements
- Curt Calaway Appointed CFO at Tyson Foods, Inc.
- Stran & Company Responds to Nasdaq Notification on Filing Delay
- NVIDIA Schedules Event for Financial Community Engagement
- Dollar General's Stock Declines Amid Outlook Cut
- Current Water Technologies Reports Q2 2024 Financial Results
- Constellation Brands Announces Q2 Fiscal 2025 Financial Results
- Great Lakes Dredge & Dock Corporation Upgraded to B- Rating
- Market Update: Dow Rises Despite Nvidia Earnings Impact
- WORK Medical Technology Group Limited Announces Exercise of Over-Allotment Option
Recent Articles
- CUBEBIO Partners with Mountain Crest V for Public Listing
- Curt Calaway Appointed CFO at Tyson Foods, Inc.
- StateHouse Reports Significant Growth in Q2 2024 Financials
- IBEX Limited Announces FY2024 Financial Results Details
- ARMOUR Residential REIT Announces Dividend Rate for September 2024
- DMG Blockchain Solutions to Showcase at 2024 Gateway Conference
- CarGurus Participation at Citi's 2024 TMT Conference
- IDEX Biometrics Issues Incentive Subscription Rights
- Bureau Veritas: Share and Voting Rights Update
- Nokia Corporation Manager Transaction Update
- Life Science Analytics Market Forecast and Trends
- QuantaSing Group Limited Announces FY 2024 Annual Report
- Celebrating National Black Business Month with Thumzup
- Shenzhen Tomorrow Innovation Strengthens AI with Guji Acquisition
- Electra Partners with Altitude Capital for Battery Supply Chain
- Tonix Pharmaceuticals Presents TNX-102 SL Data at MHSRS 2024
- Nordic American Tankers Ltd's Positive Growth and Dividends
- Evaluating Rivian and Archer: Growth Potential and Risks
- Medigene AG Expands Patent Portfolio for Cancer Therapies
- Wolters Kluwer Share Buyback Update and Future Initiatives
- STG Global Finance Announces Debt Instrument Tender Offer
- Investing Insights: Why IBM is a Smart Choice
- Nvidia Reports Strong Q2 Earnings Amid Growth Concerns
- Euro Manganese Seeks Strategic Project Status under CRMA
- Greystone Housing Impact Investors LP Shares Schedule K-3